ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,503, issued on Nov. 25, was assigned to Glaukos Corp. (Aliso Viejo, Calif.).
"Implants with controlled drug delivery features and methods of using same" was invented by David S. Haffner (Mission Viejo, Calif.), Thomas W. Burns (Dana Point, Calif.), Harold A. Heitzmann (Irvine, Calif.) and Kenneth M. Curry (Oceanside, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled rel...